ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,432Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 738

$1.39M Total Retail Price of All Prescriptions

Rank: 15 out of 738

489 Patients Receiving at Least One Drug in Part D
15%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 489 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

9% of this provider’s 1,404 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$122 was the average price of a prescription from this provider, compared to $113 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
TRAZODONE HCL 699 105 1 1
LEVETIRACETAM 522 23 2 78
FLUOXETINE HCL 425 37 3 8
QUETIAPINE FUMARATE 398 51 4 9
HYDROXYZINE PAMOATE 367 13 R 5 32
CLOZAPINE 348 0 6 31
FANAPT 346 15 10 7 83
CITALOPRAM HBR 306 48 8 4
BENZTROPINE MESYLATE 281 19 R 9 6
VENLAFAXINE HCL ER 270 35 10 19
SERTRALINE HCL 265 33 11 5
GABAPENTIN 258 40 12 33
TOPIRAMATE 256 0 13 39
DIVALPROEX SODIUM 250 29 14 23
RISPERIDONE 248 20 15 2
SEROQUEL XR 245 19 16 13
BUPROPION HCL SR 236 0 17 22
PERPHENAZINE 216 11 18 42
PRISTIQ ER 209 53 19 41
CYMBALTA 209 19 19 11
ZOLPIDEM TARTRATE 208 69 21 3
BUSPIRONE HCL 208 13 21 20
MIRTAZAPINE 197 56 23 10
ESCITALOPRAM OXALATE 197 58 23 14
LITHIUM CARBONATE 195 38 25 25
SEROQUEL 178 22 26 27
HALOPERIDOL 165 28 27 29
OXCARBAZEPINE 159 25 28 44
VENLAFAXINE HCL 153 23 29 40
HYDROXYZINE HCL 146 46 R 30 59
DIVALPROEX SODIUM ER 132 27 31 24
OLANZAPINE 129 13 32 18
PAROXETINE HCL 129 18 32 16
ZIPRASIDONE HCL 124 20 34 36
ABILIFY 115 12 35 7
PROMETHAZINE HCL 104 19 R 36 106
SAPHRIS 100 0 37 73
VIIBRYD 96 0 38 71
TRIFLUOPERAZINE HCL 90 0 39 57
THIORIDAZINE HCL 90 0 R 39 90
LAMOTRIGINE 89 0 41 12
CARBAMAZEPINE 86 0 42 49
TRIHEXYPHENIDYL HCL 86 12 R 42 46
DOXEPIN HCL 75 0 44 45
LEXAPRO 75 20 44 35
NORTRIPTYLINE HCL 74 23 46 80
CLONAZEPAM 73 25 47 30
KETOPROFEN 67 0 48 180
BUPROPION XL 62 23 49 15
INVEGA 58 0 50 61
AMITRIPTYLINE HCL 58 20 R 50 47
AMPHETAMINE SALT COMBO 58 0 S2 50 37
GEODON 55 0 53 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 27, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.